Authors:
JACOBS MR
STRAUSS ME
PATTERSON MB
MACK JL
Citation: Mr. Jacobs et al., CHARACTERIZATION OF DEPRESSION IN ALZHEIMERS-DISEASE BY THE CERAD BEHAVIOR RATING-SCALE FOR DEMENTIA (BRSD), The American journal of geriatric psychiatry, 6(1), 1998, pp. 53-58
Citation: Mr. Jacobs, ANTIBIOTIC-RESISTANT STREPTOCOCCUS-PNEUMONIAE IN ACUTE OTITIS-MEDIA -OVERVIEW AND UPDATE, The Pediatric infectious disease journal, 17(10), 1998, pp. 947-952
Authors:
VISALLI MA
BAJAKSOUZIAN S
JACOBS MR
APPELBAUM PC
Citation: Ma. Visalli et al., SYNERGISTIC ACTIVITY OF TROVAFLOXACIN WITH OTHER AGENTS AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE ORGANISMS, Diagnostic microbiology and infectious disease, 30(1), 1998, pp. 61-64
Authors:
VENKATAPRASAD N
JACOBS MR
JOHNSON JL
KLOPMAN G
ELLNER JJ
Citation: N. Venkataprasad et al., ACTIVITY OF NEW QUINOLONES AGAINST INTRACELLULAR MYCOBACTERIUM-AVIUM IN HUMAN MONOCYTES (VOL 40, PG 841, 1997), Journal of antimicrobial chemotherapy, 41(6), 1998, pp. 674-674
Citation: Lm. Ednie et al., ANTIANAEROBIC ACTIVITY OF ERYTHROMYCIN, AZITHROMYCIN AND CLARITHROMYCIN - EFFECT OF PH ADJUSTMENT OF MEDIA TO COMPENSATE FOR PH SHIFT CAUSED BY INCUBATION IN CO2, Journal of antimicrobial chemotherapy, 41(3), 1998, pp. 387-389
Citation: Cl. Clark et al., ANTIPNEUMOCOCCAL ACTIVITIES OF LEVOFLOXACIN AND CLARITHROMYCIN AS DETERMINED BY AGAR DILUTION, MICRODILUTION, E-TEST, AND DISK DIFFUSION METHODOLOGIES, Journal of clinical microbiology (Print), 36(12), 1998, pp. 3579-3584
Authors:
JACOBS MR
BAJAKSOUZIAN S
PALAVECINOFASOLA EL
HOLOSZYC HM
APPELBAUM PC
Citation: Mr. Jacobs et al., DETERMINATION OF PENICILLIN MICS FOR STREPTOCOCCUS-PNEUMONIAE BY USING A 2-DISK OR 3-DISK DIFFUSION PROCEDURE, Journal of clinical microbiology, 36(1), 1998, pp. 179-183
Authors:
CREGER RJ
WEEMAN KE
JACOBS MR
MORRISSEY A
PARKER P
FOX RM
LAZARUS HM
Citation: Rj. Creger et al., LACK OF UTILITY OF THE LYSIS-CENTRIFUGATION BLOOD CULTURE METHOD FOR DETECTION OF FUNGEMIA IN IMMUNOCOMPROMISED CANCER-PATIENTS, Journal of clinical microbiology, 36(1), 1998, pp. 290-293
Citation: Lm. Ednie et al., ACTIVITIES OF GATIFLOXACIN COMPARED TO THOSE OF 7 OTHER AGENTS AGAINST ANAEROBIC ORGANISMS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2459-2462
Citation: Ma. Visalli et al., ACTIVITIES OF 3 QUINOLONES, ALONE AND IN COMBINATION WITH EXTENDED-SPECTRUM CEPHALOSPORINS OR GENTAMICIN, AGAINST STENOTROPHOMONAS-MALTOPHILIA, Antimicrobial agents and chemotherapy, 42(8), 1998, pp. 2002-2005
Citation: Ga. Pankuch et al., POSTANTIBIOTIC EFFECT OF TROVAFLOXACIN AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE ORGANISMS, Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1503-1505
Authors:
SPANGLER SK
LIN GR
JACOBS MR
APPELBAUM PC
Citation: Sk. Spangler et al., POSTANTIBIOTIC EFFECT AND POSTANTIBIOTIC SUB-MIC EFFECT OF LEVOFLOXACIN COMPARED TO THOSE OF OFLOXACIN, CIPROFLOXACIN, ERYTHROMYCIN, AZITHROMYCIN, AND CLARITHROMYCIN AGAINST 20 PNEUMOCOCCI, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1253-1255
Citation: Ga. Pankuch et al., ANTIPNEUMOCOCCAL ACTIVITY OF GREPAFLOXACIN COMPARED TO THAT OF OTHER AGENTS BY TIME-KILL METHODOLOGY, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1263-1265
Citation: Lm. Ednie et al., COMPARATIVE ACTIVITIES OF CLINAFLOXACIN AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1269-1273
Authors:
HOELLMAN DB
VISALLI MA
JACOBS MR
APPELBAUM PC
Citation: Db. Hoellman et al., ACTIVITIES AND TIME-KILL STUDIES OF SELECTED PENICILLINS, BETA-LACTAMASE INHIBITOR COMBINATIONS, AND GLYCOPEPTIDES AGAINST ENTEROCOCCUS-FAECALIS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 857-861
Citation: Ma. Visalli et al., DETERMINATION OF ACTIVITIES OF LEVOFLOXACIN, ALONE AND COMBINED WITH GENTAMICIN, CEFTAZIDIME, CEFPIROME, AND MEROPENEM, AGAINST 124 STRAINSOF PSEUDOMONAS-AERUGINOSA BY CHECKERBOARD AND TIME-KILL METHODOLOGY, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 953-955
Authors:
HOELLMAN DB
SPANGLER SK
JACOBS MR
APPELBAUM PC
Citation: Db. Hoellman et al., IN-VITRO ACTIVITIES OF CEFMINOX AGAINST ANAEROBIC-BACTERIA COMPARED WITH THOSE OF 9 OTHER COMPOUNDS, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 495-501
Citation: Mr. Jacobs et al., PREVALENCE OF ANTIMICROBIAL-RESISTANT PATHOGENS IN MIDDLE-EAR FLUID -MULTINATIONAL STUDY OF 917 CHILDREN WITH ACUTE OTITIS-MEDIA, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 589-595
Authors:
PANKUCH GA
VISALLI MA
JACOBS MR
APPELBAUM PC
Citation: Ga. Pankuch et al., SUSCEPTIBILITIES OF PENICILLIN-SUSCEPTIBLE AND ERYTHROMYCIN-SUSCEPTIBLE AND PENICILLIN-RESISTANT AND ERYTHROMYCIN-RESISTANT PNEUMOCOCCI TO HMR-3647 (RU-66647), A NEW KETOLIDE, COMPARED WITH SUSCEPTIBILITIES TO17 OTHER AGENTS, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 624-630
Authors:
PANKUCH GA
JUENEMAN SA
DAVIES TA
JACOBS MR
APPELBAUM PC
Citation: Ga. Pankuch et al., IN-VITRO SELECTION OF RESISTANCE TO 4 BETA-LACTAMS AND AZITHROMYCIN IN STREPTOCOCCUS-PNEUMONIAE, Antimicrobial agents and chemotherapy, 42(11), 1998, pp. 2914-2918
Citation: Ga. Pankuch et al., POSTANTIBIOTIC EFFECT AND POSTANTIBIOTIC SUB-MIC EFFECT OF QUINUPRISTIN-DALFOPRISTIN AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE ORGANISMS, Antimicrobial agents and chemotherapy, 42(11), 1998, pp. 3028-3031
Authors:
PANKUCH GA
HOELLMAN DB
LIN GR
BAJAKSOUZIAN S
JACOBS MR
APPELBAUM PC
Citation: Ga. Pankuch et al., ACTIVITY OF HMR-3647 COMPARED TO THOSE OF 5 AGENTS AGAINST HAEMOPHILUS-INFLUENZAE AND MORAXELLA-CATARRHALIS BY MIC DETERMINATION AND TIME-KILL ASSAY, Antimicrobial agents and chemotherapy, 42(11), 1998, pp. 3032-3034
Authors:
SONG JH
YANG JW
PECK KR
KIM S
LEE NY
JACOBS MR
APPELBAUM PC
PAI CH
Citation: Jh. Song et al., SPREAD OF MULTIDRUG-RESISTANT STREPTOCOCCUS-PNEUMONIAE IN SOUTH-KOREA, Clinical infectious diseases, 25(3), 1997, pp. 747-749
Authors:
SYROGIANNOPOULOS GA
GRIVEA IN
BERATIS NG
SPILIOPOULOU AE
FASOLA EL
BAJAKSOUZIAN S
APPELBAUM PC
JACOBS MR
Citation: Ga. Syrogiannopoulos et al., RESISTANCE PATTERNS OF STREPTOCOCCUS-PNEUMONIAE FROM CARRIERS ATTENDING DAY-CARE-CENTERS IN SOUTHWESTERN GREECE, Clinical infectious diseases, 25(2), 1997, pp. 188-194